Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts

Epithelial ovarian cancer is the most lethal gynecological cancer and the high mortality is due to the frequent presentation at advanced stage, and to primary or acquired resistance to platinum-based therapy